# EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

> **NCT02263313** · — · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 59 (actual)

## Conditions studied

- Coronary Restenosis

## Interventions

- **OTHER:** EGO-COMBO group

## Key facts

- **NCT ID:** NCT02263313
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2014-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263313, "EGO-COMBO Clinical End-point Extension Study Beyond 36 Months". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02263313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*